SEngine Precision Medicine Company
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.
Technology:
Biotechnology, Organoids
Industry:
Early Drug Development, R&D
Headquarters:
Seattle, Washington, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
5
Total Funding:
21200000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-07-28
Last Funding Type:
Series A
Register and Claim Ownership